UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011994
Receipt No. R000014019
Scientific Title A randomized phase II study of daily administrations versus alternate-day administrations of S-1 with completely resected pathological stage I (T>2cm) of non-small cell lung cancer
Date of disclosure of the study information 2013/12/01
Last modified on 2020/10/15 13:48:20

No. Disposal Last modified on Item of update
1 Insert 2013/10/08 23:34:21
2 Update 2013/10/09 08:57:45 Date of disclosure of the study information
3 Update 2014/04/18 23:24:52 Recruitment status
4 Update 2015/12/28 21:28:59 Recruitment status
5 Update 2018/10/11 17:28:47 UMIN ID1
UMIN ID2
6 Update 2018/10/14 19:58:42 Randomization unit
Key exclusion criteria
7 Update 2018/10/14 20:06:06 Name of primary sponsor
Organization
8 Update 2019/04/12 12:18:51 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of person sending information
Name of person sending information
Email
Organization
Organization
Address
Address
Tel
Email
9 Update 2019/04/13 20:50:19 Key inclusion criteria
10 Update 2019/04/13 21:16:32 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Address
Address
Organization1
Tel1
Email1
Organization
Organization
Address
Tel
Email
Institutions
11 Update 2019/04/13 21:22:09 Number of participants that the trial has enrolled
12 Update 2019/04/13 21:28:41 Date of IRB
Last follow-up date
13 Update 2019/05/03 22:03:23 UMIN ID3
14 Update 2020/10/15 13:45:15 Key secondary outcomes
15 Update 2020/10/15 13:48:20 Last follow-up date


Contact us.